{"id":8524,"date":"2020-12-14T13:43:22","date_gmt":"2020-12-14T13:43:22","guid":{"rendered":"https:\/\/cdtrp.ca\/?p=8524"},"modified":"2020-12-14T13:43:22","modified_gmt":"2020-12-14T13:43:22","slug":"gagnant-de-la-competition-2020-cst-astellas-t3-grant-dr-istvan-mucsi","status":"publish","type":"post","link":"https:\/\/cdtrp.ca\/fr\/gagnant-de-la-competition-2020-cst-astellas-t3-grant-dr-istvan-mucsi\/","title":{"rendered":"Gagnant de la comp\u00e9tition 2020 CST-Astellas T3 Grant : Dr Istvan Mucsi"},"content":{"rendered":"

\"\"Gagnant de la comp\u00e9tition 2020 CST-Astellas T3 Grant : Dr Istvan Mucsi<\/h4>\n

Le PRDTC tient \u00e0 f\u00e9liciter le Dr Istvan Mucsi<\/strong> pour son succ\u00e8s au 2020 CST-Astellas T3 Grant competition for Improving Patient Outcomes in Transplant<\/em>. Le 26 novembre 2020, le Dr Mucsi a affront\u00e9 ses coll\u00e8gues finalistes, Anne Halpin, Marcelo Cypel et Michel Lallier, dans un Dragon’s Den<\/em> virtuel, afin de pr\u00e9senter des solutions innovantes en mati\u00e8re de transplantation \u00e0 un jury, assurant au gagnant un financement suppl\u00e9mentaire qui viendra s’ajouter \u00e0 sa bourse, d\u00e9j\u00e0 couronn\u00e9e de succ\u00e8s.<\/p>\n

Le projet de Dr. Mucsi intitul\u00e9 : \u201cEnabling informed shared decision making about living kidney donation for members of the African, Caribeean and Black (ACB) Communities- co-developing a community based framework to improve risk discussions for potential living kidney donor candidates\u201d <\/em>est ressorti grand gagnant de la f\u00e9roce comp\u00e9tition.<\/p>\n

Vous trouverez ci-dessous un r\u00e9sum\u00e9 vulgaris\u00e9 du projet gagnant (en anglais) :<\/h5>\n

\u00ab African, Caribbean and Black (ACB) kidney patients are more likely than white patients to develop end-stage kidney disease (ESKD) but less likely to receive the best treatment\u2014a living donor kidney transplant (LDKT). Longer term medica risk of live kidney donation (LKD) may be higher for people from ACB communities.<\/p>\n

Our goal is to support potential kidney transplant recipient and donor candidates from ACB communities to fully and safely explore all treatment options, LDKT by providing culturally appropriate and safe resources and opportunities to discuss and understand the pros and cons of dialysis, kidney transplant, LDKT and LKD.<\/p>\n

Experiences of discrimination and racism have created mistrust in healthcare systems among ACB members. Patient education systems in Ontario are not culturally tailored, leaving ACB Canadians with unaddressed concerns about medical interventions and treatment options.<\/p>\n

We will conduct qualitative research to better understand the risk perceptions, concepts and considerations, and the decision process concerning LKD and LDKT for ACB recipient or donor candidates. We will also explore their specific information needs about LKD and LDKT.<\/p>\n

With our partners (UHN Centre for Living Organ Donation, UHN Ajmera Transplant Centre, UHN Nephrology Division, Scarborough Hospital Nephrology Division, TAIBU Community Health Centre<\/em><\/strong>) we will co-develop a novel community-based and -informed, culturally safe patient education framework and tools, supported by nephrology and transplant outreach. This has never been tried in Canada.<\/p>\n

Better understanding of LDKT will improve access to the best treatment for ESKD and will save lives and improve quality of life of ACB patients with kidney failure. \u00bb<\/p>\n

Le PRDTC est fier de soutenir ce projet novateur qui vise \u00e0 atteindre les objectifs d’\u00e9quit\u00e9 en mati\u00e8re de sant\u00e9 et se r\u00e9jouit de diffuser les r\u00e9sultats de ce projet aupr\u00e8s de notre communaut\u00e9 au fur et \u00e0 mesure de l’avancement des travaux. Le PRDTC tient \u00e9galement \u00e0 f\u00e9liciter Anne Halpin,<\/strong> chercheuse et stagiaire du PRDTC, qui a \u00e9t\u00e9 finaliste \u00e0 la comp\u00e9tition.<\/p>\n

F\u00c9LICITATIONS!<\/h5>\n<\/div>
<\/div><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":8526,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[81,37],"tags":[],"class_list":["post-8524","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-en-vedette","category-non-classifiee"],"_links":{"self":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/8524"}],"collection":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/comments?post=8524"}],"version-history":[{"count":7,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/8524\/revisions"}],"predecessor-version":[{"id":8585,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/8524\/revisions\/8585"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/media\/8526"}],"wp:attachment":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/media?parent=8524"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/categories?post=8524"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/tags?post=8524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}